Publications 2024

Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia

Pilotto F., M Chellapandi D., Puccio H.

Trends Mol Med. 2024 Feb; doi: 10.1016/j.molmed.2023.12.002

Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?

Pilotto F., Del Bondio A., Puccio H.

Cells 2024 Feb; doi: 10.3390/cells13040319

LSD1 controls a nuclear checkpoint in Wnt/β-Catenin signaling to regulate muscle stem cell self-renewal.

Mouradian S.*, Cicciarello1 D.*, Lacoste N.*, Risson V., Berretta F., Le Grand F., Rose N., Simonet T., Schaeffer L.# and Scionti I.#.

Nucleic Acids Research 2024 Feb

H2A.Z is involved in premature aging and DSB repair initiation in muscle fibers.

Belotti E.#, Lacoste N., Iftikhar A., Simonet T., Papin C., Osseni A., Streichenberger N., Mari P-O., Girard E., Graies M., Giglia-Mari G., Dimitrov S.#, Hamiche A.#, Schaeffer L.#.

Nucleic Acids Research 2024 Jan